— Know what they know.
Not Investment Advice
Also trades as: SPL.AX (ASX) · $vol 1M · SPHRF (OTC) · $vol 0M

SPHRY Earnings

Starpharma Holdings Limited
1W: -12.2% 1M: -4.7% 3M: +9.8% YTD: +94.2% 1Y: +197.1% 3Y: +127.5% 5Y: -51.0%
$5.05
-0.80 (-13.68%)
 
Weekly Expected Move ±13.3%
$4 $4 $5 $6 $6
OTC · Healthcare · Biotechnology · Tech Score Buy · Power 68 · $212.6M mcap · 29M float · 0.0034% daily turnover · Short 57% of daily vol
Last Earnings 2026-08-25
EPS
A$-0.14 (US$-0.10)
▼ Miss +0.0%
Revenue
A$855K ($595K)
▲ Beat +0.0%

Estimate vs Actual

Earnings Surprise History

0/20
EPS Beats
0/20
Revenue Beats
0%
EPS Beat Rate
0%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-01 annual 2028-06-30 A$0.30 A$0.05 ▼ 0.25 A$38,389,882 A$26,779,887
2026-10-01 annual 2027-06-30 A$0.02 A$-0.14 ▼ 0.16 A$24,569,524 A$15,475,736
2026-08-20 annual 2027-06-30 A$-0.02 A$0.02 ▲ 0.04 A$24,268,122 A$24,569,524
2026-08-20 annual 2029-06-30 A$0.48 A$0.50 ▲ 0.02 A$55,614,446 A$56,305,161
2026-08-20 annual 2028-06-30 A$0.28 A$0.30 ▲ 0.02 A$37,918,940 A$38,389,882
2026-08-20 annual 2026-06-30 A$-0.08 A$-0.08 — A$15,976,513 A$16,174,937
2026-08-12 annual 2008-06-30 A$— A$— — A$— A$10,193,674
2026-08-12 annual 2019-06-30 A$— A$-0.34 ▼ 0.34 A$— A$5,584,052
2026-08-12 annual 2021-06-30 A$— A$-0.38 ▼ 0.38 A$— A$5,744,947
2026-08-12 annual 2016-06-30 A$— A$-0.68 ▼ 0.68 A$— A$6,171,781
2026-08-12 annual 2022-06-30 A$— A$-0.39 ▼ 0.39 A$— A$5,100,744
2026-08-12 quarter 2008-12-30 A$— A$— — A$— A$12,221,346
2026-08-12 annual 2024-06-30 A$-0.19 A$-0.19 — A$2,680,497 A$2,680,497
2026-08-12 annual 2020-06-30 A$— A$-0.25 ▼ 0.25 A$— A$11,502,907
2026-08-12 annual 2023-06-30 A$— A$-0.38 ▼ 0.38 A$— A$15,014,071
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms